Hori Katsuhito

ホリカツヒト | Hori Katsuhito

Research theme for competitive and other funds (4)：

2016 - 2019 Identification and evaluation of risk factors for severe immune-mediated adverse drug reactions using Big Data
2015 - 2019 Development of search method of drug interaction of ARB using medical information database and elucidation of the mechanism
2015 - 2018 The pharmacoepidemiological study on the adverse reaction of novel therapeutic agent for type 2 diabetes mellitus and the application
2013 - 2016 Evaluation of interaction between biotechnology-based drug and chemical drug using medical information databases

Papers (14)：

Takuya Imatoh, Kimie Sai, Mayu Takeyama, Katsunori Segawa, Takanori Yamashita, Naoki Nakashima, Yoko Kataoka, Hideto Yokoi, Tatsuo Hiramatsu, Kazuhiko Ohe, et al. Evaluating the impact of regulatory action on denosumab-induced hypocalcaemia in Japan. Journal of clinical pharmacy and therapeutics. 2019. 44. 5. 788-795
Takuya Imatoh, Kimie Sai, Mayu Takeyama, Katsuhito Hori, Masato Karayama, Kazuki Furuhashi, Katsunori Segawa, Michio Kimura, Junichi Kawakami, Yoshiro Saito. Identification of risk factors and development of detection algorithm for denosumab-induced hypocalcaemia. Journal of clinical pharmacy and therapeutics. 2019. 44. 1. 62-68
Katsuhito Hori, Michio Kimura, Kazuhiko Ohe, Naoki Nakajima, Hideto Yokoi, Masahiro Tohkin, Kimie Sai, Takuya Imatoh, Tsugumichi Sato, Syunya Ikeda, et al. Review of the Pharmacoepidemiological Studies Using the Medical Information Databases in Japanese Hospitals. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2016. 25. 315-316
Tadaaki Hanatani, Kimie Sai, Masahiro Tohkin, Katsunori Segawa, Michio Kimura, Katsuhito Hori, Junichi Kawakami, Yoshiro Saito. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale. Pharmacoepidemiology and drug safety. 2014. 23. 9. 984-8
Katsuhito Hori, Norihiro Kobayashi, Hitoshi Atsumi, Akira Nagayama, Masako Kondoh, Ichiro Noge, Midori Kimura, Hiroaki Utsugi, Tsuyoshi Iwasaki, Masaki Nakamura, et al. Changes in compliance with Japanese antiemetic guideline for chemotherapy-induced nausea and vomiting: a nationwide survey using a distributed research network. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2014. 22. 4. 969-77

ｍore...

MISC (53)：

三浦文美, 堀雄史, 川上純一. 病院データベースを用いた抗悪性腫瘍薬白金製剤に関連する聴覚障害の検出及び各薬剤間の比較. 日本緩和医療薬学会年会プログラム・要旨集. 2021. 14th
堀雄史. リスクマネジメント業務において薬剤師GRMが担う役割. 日本病院薬剤師会雑誌. 2021. 57. 9
津田重城, 小山弘子, 古閑晃, 村上恭子, 小原拓, 平河威, 堀雄史, 宮崎真. 日本においてワクチンの適正使用の基盤を構築するために. 医薬品医療機器レギュラトリーサイエンス. 2020. 51. 11. 591-598
山下貴範, 堀雄史, 堀田多恵子, 山上浩志, 中島直樹, 康東天. データ駆動型臨床研究ノススメ MID-NETの経験から. 医療情報学連合大会論文集. 2020. 40回. 204-206
堀雄史. 医療情報データベースを用いた研究および病院薬剤部のMID-NETへの関わり. 医療情報学連合大会プログラム・抄録集. 2020. 40th

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page